Literature DB >> 17126312

Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood.

Maria Rissanen1, Pauliina Helo, Riina-Minna Väänänen, Veikko Wahlroos, Hans Lilja, Martti Nurmi, Kim Pettersson, Jussi Nurmi.   

Abstract

OBJECTIVES: The purpose of this study was to design, validate, and optimize internally standardized real-time quantitative RT-PCR assays and to identify and avoid problems with assay reliability and examine the impact of an exogenous internal standard. DESIGN AND METHODS: The model system consisted of internally standardized quantitative real-time RT-PCR assays specific for PSA and hK2 mRNA based on time-resolved fluorometric detection of lanthanide chelates.
RESULTS: Reproducibility was best when large copy numbers (>5000 per milliliter blood) were analyzed. Addition of an exogenous target-mimicking internal standard had no significant effect on the reproducibility of the method, but increased the calculated copy numbers by an average of 2-fold.
CONCLUSIONS: We developed an internally standardized, specific and reproducible real-time RT-PCR analysis method for PSA and hK2 mRNA in circulating cells in the bloodstream. Both PSA and hK2 assays are sufficiently sensitive to detect two LNCaP cells per milliliter whole blood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126312     DOI: 10.1016/j.clinbiochem.2006.10.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.

Authors:  Pauliina Helo; Angel M Cronin; Daniel C Danila; Sven Wenske; Rita Gonzalez-Espinoza; Aseem Anand; Michael Koscuiszka; Riina-Minna Väänänen; Kim Pettersson; Felix K-H Chun; Thomas Steuber; Hartwig Huland; Bertrand D Guillonneau; James A Eastham; Peter T Scardino; Martin Fleisher; Howard I Scher; Hans Lilja
Journal:  Clin Chem       Date:  2009-02-20       Impact factor: 8.327

2.  Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens.

Authors:  Riina-Minna Väänänen; Hans Lilja; Leni Kauko; Pauliina Helo; Henna Kekki; Angel M Cronin; Andrew J Vickers; Martti Nurmi; Kalle Alanen; Anders Bjartell; Kim Pettersson
Journal:  Urology       Date:  2014-02       Impact factor: 2.649

3.  Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.

Authors:  Riina-Minna Väänänen; Hans Lilja; Angel Cronin; Leni Kauko; Maria Rissanen; Otto Kauko; Henna Kekki; Siina Vidbäck; Martti Nurmi; Kalle Alanen; Kim Pettersson
Journal:  Clin Biochem       Date:  2013-02-04       Impact factor: 3.281

Review 4.  Circulating biomarkers for prostate cancer.

Authors:  Thomas Steuber; Pauliina Helo; Hans Lilja
Journal:  World J Urol       Date:  2007-03-08       Impact factor: 4.226

5.  Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates.

Authors:  Riina-Minna Väänänen; Natalia Tong Ochoa; Peter J Boström; Pekka Taimen; Kim Pettersson
Journal:  BMC Urol       Date:  2015-08-21       Impact factor: 2.264

6.  Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.

Authors:  Saeid Alinezhad; Riina-Minna Väänänen; Natalia Tong Ochoa; Emily A Vertosick; Anders Bjartell; Peter J Boström; Pekka Taimen; Kim Pettersson
Journal:  BMC Urol       Date:  2016-02-29       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.